Prem Watsa’s Xeris Biopharma Holdings XERS Stock Holding History

Prem Watsa’s Portfolio XERS Stock Details XERS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-139,687	Closed	-$472K	–	31
2024 Q4	$472K	Sell	139,687 -31,250	-18%	-$101K	0.03%	30
2024 Q3	$485K	Hold	170,937	–	–	0.04%	31
2024 Q2	$383K	Buy	170,937 +19,542	+13%	+$39.4K	0.03%	37
2024 Q1	$333K	Hold	151,395	–	–	0.03%	42
2023 Q4	$356K	Hold	151,395	–	–	0.02%	57
2023 Q3	$282K	Hold	151,395	–	–	0.02%	60
2023 Q2	$395K	Hold	151,395	–	–	0.02%	60
2023 Q1	$245K	Hold	151,395	–	–	0.01%	64
2022 Q4	$200K	Hold	151,395	–	–	0.01%	73
2022 Q3	$236K	Hold	151,395	–	–	0.01%	69
2022 Q2	$232K	Hold	151,395	–	–	0.01%	67
2022 Q1	$388K	Hold	151,395	–	–	0.01%	65
2021 Q4	$441K	Buy	+151,395	New	+$327K	0.01%	60

Other funds holding XERS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Prem Watsa's XERS Position: Q1 2025 in Review

Prem Watsa sold out of Xeris Biopharma Holdings (XERS) in Q1 2025, closing a stake of 139,687 shares — an estimated $472K sold.

Prem Watsa first reported a position in XERS in Q4 2021 and held it in 13 quarters. The position peaked at $485K in Q3 2024. 199 funds tracked by Wall St. Rank hold XERS as of Q1 2025.

Prem Watsa reported no remaining Xeris Biopharma Holdings position as of Q1 2025 after selling out during the quarter.
Prem Watsa sold 139,687 Xeris Biopharma Holdings shares in Q1 2025, an estimated $472K.
Prem Watsa first reported a position in Xeris Biopharma Holdings in Q4 2021 and held it in 13 quarters.
Prem Watsa's Xeris Biopharma Holdings position peaked at $485K in Q3 2024.
199 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q1 2025.

Based on Fairfax Financial Holdings's 13F filing for Q1 2025, filed 15 May 2025.